7 Jun 2018 07:00
7th June 2018 This announcement contains inside information
Wilmcote Holdings plc
Statement re media speculation
Wilmcote Holdings plc ('Wilmcote'), established in 2017 to acquire and subsequently develop target businesses in the chemicals sector, notes the recent press speculation and confirms that it is in discussions with Platform Specialty Products ('Platform') regarding a potential acquisition of its Agricultural Solutions segment, Arysta LifeScience.
The discussions are ongoing and as such there is no certainty that any transaction will proceed between Wilmcote and Platform. A further announcement will be made as appropriate.
In accordance with Rule 14 of the AIM Rules, Wilmcote's ordinary shares will be suspended from trading on AIM with effect from 7.30am, 7th June. The Company's ordinary shares will remain suspended pending compliance with Rule 14 or until such time an announcement is released confirming that the potential acquisition is not proceeding.
-ENDS-
Teneo (Financial PR) Tel: +44 (0) 7703 330 269Charles Armitstead/ Rosie Oddy
Numis Securities Limited (Nominated Adviser and Broker) Tel: +44 (0) 20 7260 1000
Jamie Lillywhite
Jamie Loughborough
Adrian Whitfield is Chief Executive Officer of Wilmcote Holdings plc, which has its offices at 11 Buckingham Street, London WC2N 6DF and has the LEI number 2138004EUUU11OVHZW75.